Pharma distributor’s licence cancelled over Kota postpartum deaths; WHO seeks report
The World Health Organization has requested information from India regarding the supply of potentially spurious oxytocin injections linked to postpartum deaths in Kota. Consequently, the manufacturing licenses for Jackson Laboratories have been cancelled following inspections by drug regulators.
Why it matters
This incident highlights the importance of pharmaceutical quality control and international oversight in ensuring patient safety in public hospitals.
The World Health Organization (WHO) has sought information from the Government of India on the alleged supply of spurious oxytocin injections to government hospitals in Kota by a pharma distributor, leading to the deaths of five women following Caesarean deliveries in May.
The report objectively details the regulatory actions taken by the government and the inquiry initiated by the WHO.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in